Preventive Vaccines Global Market Report 2025

Preventive Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on preventive vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for preventive vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The preventive vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Type: Live Or Attenuated Vaccines; Inactivated Vaccines; Toxoid Vaccines; Subunit Vaccines; Conjugate Vaccines; DNA Vaccines; Recombinant Vector Vaccines

2) By Disease Type: Pneumococcal; Poliovirus; Hepatitis; Influenza; Measles; Rubella; Other Disease Types

3) By Age Group: Pediatric; Adult; Geriatric

4) By Distribution Channel: Hospitals; Clinics; Pharmacies; Other Distribution Channels

Subsegments:

1) By Live or Attenuated Vaccines: Measles, Mumps, and Rubella (MMR) Vaccine; Varicella (Chickenpox) Vaccine; Oral Polio Vaccine (OPV); Yellow Fever Vaccine; Rotavirus Vaccine; Bacillus Calmette-Guérin (BCG) Vaccine

2) By Inactivated Vaccines: Inactivated Poliovirus Vaccine (IPV); Hepatitis A Vaccine; Rabies Vaccine; Influenza (Inactivated) Vaccine; Japanese Encephalitis Vaccine

3) By Toxoid Vaccines: Tetanus Toxoid Vaccine; Diphtheria Toxoid Vaccine; Pertussis (whooping cough) Vaccine

4) By Subunit Vaccines: Hepatitis B Vaccine; Human Papillomavirus (HPV) Vaccine; Pertussis (acellular) Vaccine; Influenza (recombinant protein) Vaccine

5) By Conjugate Vaccines: Pneumococcal Conjugate Vaccine (PCV); Haemophilus influenzae type b (Hib) Vaccine; Meningococcal Conjugate Vaccine

6) By DNA Vaccines: Zika Virus DNA Vaccine; Cytomegalovirus (CMV) DNA Vaccine; Infectious Disease DNA Vaccines

7) By Recombinant Vector Vaccines: Ebola Vaccine (rVSV-ZEBOV); COVID-19 Recombinant Vector Vaccines; Dengue Recombinant Vector Vaccines

Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Sanofi Pasteur SA; AstraZeneca plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Preventive Vaccines Market Characteristics
3. Preventive Vaccines Market Trends And Strategies
4. Preventive Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Preventive Vaccines Growth Analysis And Strategic Analysis Framework
5.1. Global Preventive Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Preventive Vaccines Market Growth Rate Analysis
5.4. Global Preventive Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Preventive Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Preventive Vaccines Total Addressable Market (TAM)
6. Preventive Vaccines Market Segmentation
6.1. Global Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Live Or Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Subunit Vaccines
Conjugate Vaccines
DNA Vaccines
Recombinant Vector Vaccines
6.2. Global Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pneumococcal
Poliovirus
Hepatitis
Influenza
Measles
Rubella
Other Disease Types
6.3. Global Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Pharmacies
Other Distribution Channels
6.4. Global Preventive Vaccines Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pediatric
Adult
Geriatric
6.5. Global Preventive Vaccines Market, Sub-Segmentation Of Live or Attenuated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Measles, Mumps, and Rubella (MMR) Vaccine
Varicella (Chickenpox) Vaccine
Oral Polio Vaccine (OPV)
Yellow Fever Vaccine
Rotavirus Vaccine
Bacillus Calmette-Guérin (BCG) Vaccine
6.6. Global Preventive Vaccines Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inactivated Poliovirus Vaccine (IPV)
Hepatitis A Vaccine
Rabies Vaccine
Influenza (Inactivated) Vaccine
Japanese Encephalitis Vaccine
6.7. Global Preventive Vaccines Market, Sub-Segmentation Of Toxoid Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tetanus Toxoid Vaccine
Diphtheria Toxoid Vaccine
Pertussis (whooping cough) Vaccine
6.8. Global Preventive Vaccines Market, Sub-Segmentation Of Subunit Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hepatitis B Vaccine
Human Papillomavirus (HPV) Vaccine
Pertussis (acellular) Vaccine
Influenza (recombinant protein) Vaccine
6.9. Global Preventive Vaccines Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pneumococcal Conjugate Vaccine (PCV)
Haemophilus influenzae type b (Hib) Vaccine
Meningococcal Conjugate Vaccine
6.10. Global Preventive Vaccines Market, Sub-Segmentation Of DNA Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Zika Virus DNA Vaccine
Cytomegalovirus (CMV) DNA Vaccine
Infectious Disease DNA Vaccines
6.11. Global Preventive Vaccines Market, Sub-Segmentation Of Recombinant Vector Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ebola Vaccine (rVSV-ZEBOV)
COVID-19 Recombinant Vector Vaccines
Dengue Recombinant Vector Vaccines
7. Preventive Vaccines Market Regional And Country Analysis
7.1. Global Preventive Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Preventive Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Preventive Vaccines Market
8.1. Asia-Pacific Preventive Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Preventive Vaccines Market
9.1. China Preventive Vaccines Market Overview
9.2. China Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Preventive Vaccines Market
10.1. India Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Preventive Vaccines Market
11.1. Japan Preventive Vaccines Market Overview
11.2. Japan Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Preventive Vaccines Market
12.1. Australia Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Preventive Vaccines Market
13.1. Indonesia Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Preventive Vaccines Market
14.1. South Korea Preventive Vaccines Market Overview
14.2. South Korea Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Preventive Vaccines Market
15.1. Western Europe Preventive Vaccines Market Overview
15.2. Western Europe Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Preventive Vaccines Market
16.1. UK Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Preventive Vaccines Market
17.1. Germany Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Preventive Vaccines Market
18.1. France Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Preventive Vaccines Market
19.1. Italy Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Preventive Vaccines Market
20.1. Spain Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Preventive Vaccines Market
21.1. Eastern Europe Preventive Vaccines Market Overview
21.2. Eastern Europe Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Preventive Vaccines Market
22.1. Russia Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Preventive Vaccines Market
23.1. North America Preventive Vaccines Market Overview
23.2. North America Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Preventive Vaccines Market
24.1. USA Preventive Vaccines Market Overview
24.2. USA Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Preventive Vaccines Market
25.1. Canada Preventive Vaccines Market Overview
25.2. Canada Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Preventive Vaccines Market
26.1. South America Preventive Vaccines Market Overview
26.2. South America Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Preventive Vaccines Market
27.1. Brazil Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Preventive Vaccines Market
28.1. Middle East Preventive Vaccines Market Overview
28.2. Middle East Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Preventive Vaccines Market
29.1. Africa Preventive Vaccines Market Overview
29.2. Africa Preventive Vaccines Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Preventive Vaccines Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Preventive Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Preventive Vaccines Market Competitive Landscape And Company Profiles
30.1. Preventive Vaccines Market Competitive Landscape
30.2. Preventive Vaccines Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Sanofi Pasteur SA Overview, Products and Services, Strategy and Financial Analysis
30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
31. Preventive Vaccines Market Other Major And Innovative Companies
31.1. GlaxoSmithKline plc (GSK)
31.2. Takeda Pharmaceutical Company Limited
31.3. Moderna Inc.
31.4. CSL Limited
31.5. Novavax Inc.
31.6. Emergent BioSolutions Inc.
31.7. Dynavax Technologies Corporation
31.8. Serum Institute of India Pvt. Ltd.
31.9. Vaxcyte Inc.
31.10. Bavarian Nordic A/S
31.11. Valneva SE
31.12. Panacea Biotec Ltd.
31.13. Inovio Pharmaceuticals Inc.
31.14. Mitsubishi Tanabe Pharma Corporation
31.15. Afrigen Biologics and Vaccines (Pty) Ltd.
32. Global Preventive Vaccines Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Preventive Vaccines Market
34. Recent Developments In The Preventive Vaccines Market
35. Preventive Vaccines Market High Potential Countries, Segments and Strategies
35.1 Preventive Vaccines Market In 2029 - Countries Offering Most New Opportunities
35.2 Preventive Vaccines Market In 2029 - Segments Offering Most New Opportunities
35.3 Preventive Vaccines Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings